Study details
Enrolling now
Taltz and Enstilar for Psoriasis
Psoriasis Treatment Center of Central New Jersey
NCT IDNCT04372277ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
25
Study length
about 11 months
Ages
18+
Locations
1 site in NJ
What this study is about
Researchers are testing a treatment with Enstilar when combined with Taltz for psoriasis. The trial will last 336 days, involving adults who have been on Taltz for at least 24 weeks. Participants must meet specific criteria to be included in it.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Enstilar
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Dermatology